Organon Pharma Indonesia Tbk. vs BSA Logistics Indonesia Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while BSA Logistics Indonesia Tbk. trades at Rp680 (market cap 6.12T, 8.25M 24h volume). The key difference: BSA Logistics Indonesia Tbk. is far larger — about 58.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | WBSA | |
|---|---|---|
Market Cap | 104.4B | 6.12T |
Volume | — | 8.25M |
Lot | — | 82.48K |
Turnover | — | 5.65B |
Average Price | — | 684.48 |
Value | — | 5.65B |
Indicative Equilibrium Price | — | 680 |
Indicative Equilibrium Volume | — | 1.54K |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT. BSA Logistics Indonesia Tbk. (the Company) was established based on Notarial Deed No. 19 of Emmyra Fauzi Kariana, S.H., M.Kn., dated March 19, 2021. The Company commenced its commercial operations in 2021.
Read more on WBSA →